Ninety percent of patients with relapsed/refractory acute lymphoblastic leukemia achieved complete remission after a T-cell therapy treatment targeting CD19.
Source: www.cancernetwork.com
See on Scoop.it – Stem cell news
Co-Founder of Celixir & Cell Therapy LTD – Ex Dentist & Ex Roche
Ninety percent of patients with relapsed/refractory acute lymphoblastic leukemia achieved complete remission after a T-cell therapy treatment targeting CD19.
Source: www.cancernetwork.com
See on Scoop.it – Stem cell news